Compare ASE Technology Holding Co Ltd (ASX) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ASE Technology Holding Co Ltd vs Twist Bioscience Corp — how do they compare? ASE Technology Holding Co Ltd trades at $39.01 (market cap $85.75B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: ASE Technology Holding Co Ltd is far larger — about 11.1× Twist Bioscience Corp's market cap, and ASE Technology Holding Co Ltd pays a 1.08% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| ASX | TWST | |
|---|---|---|
Market Cap | $85.75B | $7.72B |
Sector | Technology | Health |
52-Week High | $45.12 | $124.88 |
52-Week Low | $9.63 | $24.16 |
Enterprise Value | $90.15B | $7.65B |
Dividend Yield | 1.08% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ASE Technology Holding Co Ltd
ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, packaging services contribute the most revenue. It involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufacture and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.
Read more on ASX →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
